1.The Clinical Experience of Professor Fu Ping in the Treatment of Polycystic Ovary Syndrome
Journal of Zhejiang Chinese Medical University 2014;(1):36-39
[Objective] Discussion on academic ideas and clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome. [Methods] From the etiology and pathogenesis, therapeutic principle and therapy to expound the academic viewpoints and clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome, the prescription and Chinese medicine conditioning characteristics are summarized, and exemplify that. [Results] Professor Fu Ping believes that the pathogenesis of this disease is a virtual reality, such as phlegm and blood stasis;according to the etiology and pathogene-sis, strengthening the body resistance to eliminate pathogenic factors, coordinating Chong and Conception Vessels is the main rule; dissipating phlegm and removing dampness, warming the kidney and strengthening the spleen, nourishing liver kidney, regulating qi and activating blood is the clinical common therapy, clinical y obtaining better therapeutic effect. [Conclusion] The clinical experience of Professor Fu Ping in treatment of polycystic ovary syndrome is effective, has the value of popularization and application.
2.Effect of Pi transportation, dampness resolving and phlegm expelling herbs on the obesity degree, fat hormones, and leptin resistance in diet-induced obesity rats.
Chinese Journal of Integrated Traditional and Western Medicine 2014;34(8):997-1002
OBJECTIVETo observe the effect of Pi transportation, dampness resolving and phlegm expelling herbs (PTDRPEH) on the obesity degree, fat hormones, and leptin resistance in diet-induced obesity (DIO) rats.
METHODSAmong the 120 Wister rats, 10 were recruited as the blank control group (fed with basal forage), and the remaining 110 were administered with high-fat high-nutrition forage for 17 weeks. According to weight, we obtained 40 DIO rats and 10 diet-induced obesity resistance (DIO-R) rats. DIO rats were further divided into four groups, i.e., the DIO model group (normal saline, at the daily dose of 2 mL), the sibutramine group (at the daily dose of 1.6 mg/kg), the dampness resolving and phlegm expelling group (DRPE, at the daily dose of 3.2 g/kg), and the Pi transportation group (PT, at the daily dose of 3.2 g/kg). All were given by gastrogavage. Normal saline (2 mL) was given by gastrogavage to rats in the blank control group and the DIO-R group. The basal forage was administered to rats in the blank control group, while high fat forage was continually given to rats in the remaining five groups. Their body weights and body lengths were measured after 16 weeks of gastrogavage. All intra-abdominal fat was taken out to measure the degree of obesity and fat contents. Insulin resistance index (IRI), blood glucose, triglycerides, cholesterol, leptin, neuropeptide Y (NPY), tumor necrosis factor alpha (TNF-alpha), and adiponectin were detected after blood withdrawing. Leptin, TNF-alpha, adiponectin, suppressors of cytokine signaling-3 (SOCS-3), and other relevant adipose hormones and inflammatory cytokines were examined in the fat homogenate.
RESULTSCompared with the blank control group, DIO model rats' body weight, body mass index (BMI), fat factor, IRI, serum leptin, TNF-alpha, and SOCS-3 significantly increased (P < 0.05, P < 0.01); serum NPY, serum leptin, and adiponectin decreased (P < 0.05). Leptin increased and NPY decreased in DIO-R model rats. Compared with the DIO group, DIO-R model rats' body weight, BMI, fat factor, IRI, serum NPY, TNF-alpha, and SOCS-3 all decreased (P < 0.05, P < 0.01); leptin and adiponectin in serum and the fat homogenate all increased (P < 0.05, P < 0.01). After intervention with Sibutramine, rats' body weight, BMI, fat factor, and TNF-alpha in the fat homogenate obviously decreased (P < 0.05, P < 0.01). Serum TNF-alpha decreased, leptin and adiponectin increased in rats of the DRPE group (P < 0.05, P < 0.01). BMI, fat factor, IRI, leptin, and SOCS-3 showed a decreasing tendency, but with no statistical difference (P > 0.05). The body weight, BMI, fat factor, IRI, TNF-alpha, and SOCS-3 all decreased in the PT group (P < 0.05, P < 0.01); leptin and adiponectin in the serum and the fat homogenate increased (P < 0.05, P < 0.01).
CONCLUSIONSSibutramine could reduce body weight and TNF-alpha in the adipose tissue. Herbs of PT could inhibit fat diet-induced obesity and insulin resistance (IR), with superior effect to herbs of DRPE. Its mechanism might be closely related to promoting leptin and adiponectin secreted by fat, reducing leptin resistance, and elevating serum levels of leptin and adiponectin.
Adiponectin ; blood ; Animals ; Diet, High-Fat ; Disease Models, Animal ; Drugs, Chinese Herbal ; pharmacology ; Insulin Resistance ; Leptin ; blood ; Male ; Obesity ; blood ; drug therapy ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha ; metabolism
6.Effects of aspirin on PCNA and cyclin D1 expressions in diethylnitrosamine induced hepatic cancer of the rat
Chinese Journal of General Surgery 2008;23(6):447-449
Objective To observe the effects of aspirin on PCNA and cyclin D1 expressions in diethylnitrosamine (DEN) induced hepatic cancer of the rat. Methods Sprague-Dawley (SD) rats were randomly divided into DEN group and DEN plus aspirin group. Each group was further divided into 8,12,16 week subgroups. The expressions of PCNA and cyclin D1 in hepatic tissue were examined with inmunohistochemistry. Results In DEN plus aspirin group cirrhosis was less severe and carcinoma developed later than that in DEN group. Hepatic carcinoma occurred in four rats out of six in DEN group at the 16th week (P<0.05). In DEN plus aspirin group PCNA and cyclin D1 expressions were significantly lower than those in DEN group(P <0.05) , inhibiting effects on cyclin D1 expression was evidently great at 16th week (F=11.944,P<0.05) and inhibiting effect on PCNA was obvious from 12th to 16th week (F=5.696 and F=11.057, P<0.05 ). Conclusion Aspirin downregulates the expressions of PCNA and cyclin D1 in hepatic tissues and inhibits the genesis and development of DEN induced hepatic cancer of the rats.
7.Preoperatively pulmonary function evaluation before liver transplantation in patients with end-stage liver disease
Clinical Medicine of China 2011;27(3):279-281
Objective To assess the pulmonary function before liver transplantation in patients with end-stage liver disease. Methods One hundred and fifty-four patients with end-stage liver disease, who were waiting for liver transplantation in our hospital, were enrolled into the study. The pulmonary ventilation function,small airway function and diffusion capacity were measured and analyzed respectively. Results Among 154 subjects,140 (90. 9%, 140/154) patients had abnormal pulmonary function, shown as pulmonary diffusing capacity reduction;followed by restrictive ventilatory function reduction (42. 8% ,66/154) and small airway function reduction (37. 7%, 58/154 ), the least common manifestation was obstructive ventilatory function reduction (28.6 % ,44/154 ). Conclusion Abnormal pulmonary function in patients with end-stage liver disease is common, and the pulmonary function tests before liver transplantation has certain referential value for pulmonary function damage evaluation and postoperatively respiratory tract management.
8.Effects of hemodialysis on nutritional status and water balance in newly diagnosed ESRD patients
Chinese Journal of Practical Internal Medicine 2000;0(12):-
Objective To observe the effects of hemodialysis on nutritional status and water balance in newly diagnosed end-stage renal disease(ESRD)patients.Methods Thirty newly diagnosed ESRD patients who accepted hemodialysis for the first time were included in the study;body water balance was analyzed by bioelectric impedance analysis(BIA)method and nutritional status were evaluated by BIA,anthropometry and blood biochemical indicators.Results Total body water,extracellular fluid,intracellular fluid,normalized total body water,normalized extracellular fluid,normalized intracellular fluid were decreased significantly after 3 months of hemodialysis(P
10.Effect of Shengqing Herbs on Leptin Resistance of Diet-Induced Obesity Rats
Chinese Journal of Information on Traditional Chinese Medicine 2014;(8):60-62,63
Objective To observe the effects of Shengqing Chinese herbs on the obesity and leptin resistance of diet-induced obesity (DIO) rats.Methods Wistar rats were produced a rat model including of 40 DIO rats and 10 DIO-R rats. The DIO rats were divided into DIO model group, sibutramine group, Jianpi Liqi group and Shengqing group, which were respectively by gavage of saline, sibutramine, Jianpi Liqi herbs (Citri reticulatae pericarpium, Aucklandiae radix, Aurantii fructus immaturus), Shengqing herbs (Bupleuri radix, Cimicifugae rhizoma, Puerariae lobatae radix), blank control group and DIO-R group were by gavage of saline. Their weight, were examined after 16 weeks gavage. Leptin and neuropeptide Y in the serum were examined. Leptin, TNF-α, and suppressors of cytokine signaling-3 (SOCS-3) in the homogenized fat were examined. Results Compared with the DIO-R group, DIO model group's body weight, NPY significantly increased (P<0.01);leptin in the serum and homogenized fat decreased (P<0.05);SOCS-3 increased (P<0.05). After drug intervention, weight of each drug group declined. Compared with the DIO model group, Jianpi Liqi group's leptin in the homogenized fat increased (P<0.05). Shengqing group's leptin in homogenized fat increased, body weight reduced, NPY and SOCS-3 levels decreased, and better than sibutramine group and Jianpi Liqi group (P<0.05,P<0.01).Conclusion Shengqing herbs can reduce obesity and inhibit leptin resistance.